Semaglutide has an elimination half-life of approximately one week, meaning it takes about five to seven weeks after your last dose to fully clear from your body. That’s unusually long compared to most medications, and it’s the same property that makes once-weekly dosing possible in the first place.
What the Half-Life Means in Practice
A drug’s half-life is how long it takes for the amount in your blood to drop by half. For semaglutide, FDA clinical pharmacology reviews put this figure between 6.2 and 7 days depending on the study, with the most commonly cited estimate being about one week. After one week, half the drug remains. After two weeks, a quarter remains. After three weeks, an eighth. This slow, stepwise decline continues until the amount left is too small to have any meaningful effect.
Pharmacologists generally consider a drug “cleared” after about five half-lives. For semaglutide, that works out to roughly five weeks, though trace amounts may linger slightly longer. This is why it takes four to five weeks of weekly injections to reach steady-state levels when you first start the medication. The buildup and the washout are mirror images of each other.
Oral and Injectable Forms Clear at the Same Rate
Whether you take semaglutide as a weekly injection (Ozempic, Wegovy) or a daily tablet (Rybelsus), the elimination timeline is the same. The oral form uses a special absorption enhancer to get through the stomach lining, but once semaglutide reaches the bloodstream, it is distributed, metabolized, and eliminated identically regardless of how it got there. The roughly one-week half-life applies to all forms.
How Your Body Breaks It Down
Semaglutide is a modified version of a natural gut hormone called GLP-1. Your body breaks it down through the same process it uses for proteins generally: enzymes clip the peptide backbone into smaller fragments, and the fatty acid chain attached to the molecule undergoes a stepwise breakdown. This isn’t confined to any single organ like the liver or kidneys. It happens throughout the body.
The byproducts leave mainly through urine, with feces as a secondary route. Only about 3% of a dose shows up in urine as intact semaglutide. The rest has already been broken into smaller fragments by the time it’s excreted. In human studies, about 75% of the administered dose was recovered through these two routes combined.
Kidney or Liver Problems Don’t Change the Timeline Much
Because semaglutide is broken down throughout the body rather than relying heavily on a single organ, impaired kidney or liver function doesn’t dramatically alter how quickly it clears. The FDA review for semaglutide notes that its systemic behavior remains consistent across different patient populations. This is one reason no dose adjustment is required for people with kidney or liver disease, though the medication’s effects on appetite and digestion still warrant monitoring in those groups.
How Long Side Effects Last After Stopping
If you’ve been dealing with nausea, reduced appetite, or slower digestion while on semaglutide, those effects will fade as drug levels drop. Since it takes several weeks for the medication to fully clear, don’t expect side effects to vanish overnight. Most people notice a gradual return of normal appetite and digestion over the first two to four weeks after their final dose, tracking roughly with the declining drug levels in their blood.
The appetite-suppressing effects follow the same timeline. Weight regain studies consistently show that hunger and food cravings begin returning within weeks of stopping, and this aligns with what the pharmacokinetics predict. By five to seven weeks out, the drug’s direct influence on your body has essentially ended.
Surgery and Semaglutide
Semaglutide slows stomach emptying, which raised early concerns about aspiration risk during anesthesia. Updated multi-society guidance from the American Society of Anesthesiologists, released in late 2024, takes a more nuanced approach than earlier blanket recommendations to stop the drug weeks before surgery. Most patients can continue their GLP-1 medications before elective procedures. For those at the highest risk of gastrointestinal complications, the guidance recommends a liquid-only diet for 24 hours before surgery and the use of a bedside ultrasound to check stomach contents, rather than requiring a specific stop date.
If your surgical team does ask you to stop semaglutide before a procedure, expect them to factor in that five-week clearance window when planning your timeline.
The Two-Month Rule for Pregnancy Planning
Manufacturers recommend stopping semaglutide at least two months (eight weeks) before attempting to conceive. This lines up neatly with the pharmacokinetics: eight weeks is roughly eight half-lives, which provides a generous margin beyond the five half-lives needed for functional clearance. The goal is to ensure no meaningful drug exposure during the earliest weeks of pregnancy, when organ development begins. If you’re planning a pregnancy, that two-month washout period is the standard recommendation across clinical guidelines.